Prostate Hypoxia - TIC
Hypoxia and Stem Cell Content as Aggression Factors in Prostate Cancer
Sponsor: University Health Network, Toronto
A NA clinical study on Prostate Cancer, this trial is ongoing. The trial is conducted by University Health Network, Toronto and has accumulated 11 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Jun 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Nov 2021 — Jun 2023 [monthly]
Active Not Recruiting NA
-
May 2021 — Nov 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 6 earlier versions
-
Jan 2021 — May 2021 [monthly]
Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
-
May 2019 — Sep 2020 [monthly]
Recruiting NA
-
Jul 2018 — May 2019 [monthly]
Recruiting NA
-
Jun 2018 — Jul 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Sep 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Health Network, Toronto
For direct contact, visit the study record on ClinicalTrials.gov .